Antibody response to SARS-CoV-2 vaccination or infection in a prospective cohort of children with neuroinflammatory diseases

CONCLUSION: SARS-CoV-2 antibodies are decreased in children on CD20 monoclonal antibodies than on other treatments. Treatment duration associated with vaccination responses.PMID:37399703 | PMC:PMC10307668 | DOI:10.1016/j.ejpn.2023.06.009
Source: European Journal of Paediatric Neurology - Category: Neurology Authors: Source Type: research